1 / 6

A Local Tool to Assess the C-E Ratio of Alternative Prevention Strategies

A Local Tool to Assess the C-E Ratio of Alternative Prevention Strategies. Health Economics (MPH) Spring 2008 University of Copenhagen Prepared by: Niels Boye. Background. Structural reform + New Healh Act gives LA reponsibility for local prevention

vevina
Download Presentation

A Local Tool to Assess the C-E Ratio of Alternative Prevention Strategies

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. A Local Tool to Assess the C-E Ratio of Alternative Prevention Strategies Health Economics (MPH) Spring 2008 University of Copenhagen Prepared by: Niels Boye

  2. Background • Structural reform + New Healh Act gives LA reponsibility for local prevention • Pharmacies may be key partner for LA as provider of healthcare and of training • Objective: Better compliance for elderly people 65 years+ using more than 5 med. • Tool: Medical assessment (individual) + Training of personnel (groups) + Quality Control of routines (carehomes).

  3. Conceptual Framework • Simple input-output model (indicator) to calculate costs and benefits related to the intervention incl. costs and benefits of alt. interventions • Define key parameters (evidence reports) • Intervention scenarios • Demonstrate how C-E Ratios might change if the values of key parameters in a model change

  4. Method – ”Dogme regler” • All data is existing and free of charge • Data from official sources and opdated regularly (yearly/bi-yearly) • Data at local level (reg. / nat. / int.) • Only economic Costs and Benefits no value on extra Quality of Life • No unrelated medical cost, e.g. - healthcare cost in additional years - consumption in additional years

  5. Intervention(s) – Nat.level

  6. Summary • C-E Ratio of Pharmaceutical Care = - 0,35 (ROI 300 pct.) • Pot. economic gain = Euro 312 per person / 50 mio. (140.000 people 65+) • Extra Quality of Life (Compliance) • Political: Better Public Health • Next step: Local evidence based on local context (establish local evaluation-networks with joint database)

More Related